Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryosurgery and NK Immunotherapy in Advanced NSCLC
NCT02843815Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Jul 2016
- Primary completion
- Jul 2017
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Fuda Cancer Hospital. Primary endpoint: Relief degree at 3 months. Started Jul 2016; status: completed.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02843815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02843815.